Day-care Unit for Patients With Refractory Heart Failure

Silesian Centre for Heart Diseases200 enrolled

Overview

The Day-Care Unit for Patients With Refractory Heart Failure (DayCare-HF) is an observational study on selected patients with advanced refractory heart failure. The purpose of the study was to examine the comprehensive management of HF in the day-care unit in terms of the safety and its impact on the rehospitalization and mortality rates in patients with advanced refractory HF.

The Day-Care Unit for Patients With Refractory Heart Failure (DayCare-HF) is a single-center observational study conducted in the 3rd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease in Zabrze, Poland. The main objective of the DayCare-HF is to verify the hypothesis that comprehensive and multidisciplinary day-care management of patients with refractory heart failure (HF) is safe and beneficial in terms of hospital readmission due to HF and al cause mortality. The study population is formed by selected patients with heart failure, hospitalized in cardiology wards and intensive cardiac care unit of Silesian Centre for Heart Disease, who fulfilled eligibility criteria. During the scheduled visits comprehensive medical service is provided, including education, diagnostic tools (electrocardiography, transthoracic echocardiography, implanted cardioverter defibrillator (ICD) / cardiac resynchronization therapy device (CRT) interrogation and additional treatment (intravenous loop diuretic, dobutamine, vasodilators administration). The patients are under constant follow-up for major adverse events, heart transplantation, hospital readmissions due to HF and all cause mortality.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

200

Conditions

Heart Failure Heart Diseases Cardiovascular Diseases

Interventions

treatment in day-care heart failure unitOTHER

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Optimally decongested heart failure in New York Heart Association (NYHA) class II-IV, treated for at least 6 months 2. Performance of all possible reparative procedures if indications were present (cardiac revascularization, correction of valvular heart disease, cardiac ablation, cardiac resynchronization therapy) 3. Implantation of cardioverter-defibrillator (ICD) if applicable 4. At least two unplanned hospitalizations for heart failure during preceding 6 months Exclusion Criteria: 1. Inability to travel to the unit 2. Non-compliance with the medical recommendations

Locations (1)

Silesian Centre for Heart Disease

Zabrze, Silesian Voivodeship, Poland

Outcomes

Primary Outcomes

Number of participants with rehospitalization due to heart failure decompensation

Time frame: From date of inclusion until the date of death from any cause, assessed up to 1 year

Secondary Outcomes

Number of participants with major adverse cardiovascular event

Time frame: From date of inclusion until the date of death from any cause, assessed up to 1 year

Number of participants with reported deaths from any cause

Time frame: From date of inclusion until the date of death from any cause, assessed up to 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.